{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:36:49Z","timestamp":1786397809602,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The persistence of myofibroblasts is a key feature of fibrosis and in fibrotic diseases including scleroderma. This review evaluates the emerging concepts of the origins and cell populations that contribute to myofibroblasts and the molecular mechanisms that govern phenotypic conversion and that highlight opportunities for new interventional treatments in scleroderma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Studies have defined heterogeneity in fibroblast-like cells that can develop into myofibroblast in normal wound healing, scarring and fibrosis. Characterizing these distinct cell populations and their behaviour has been a key focus. In addition, the overarching impact of epigenetic regulation of genes associated with inflammatory responses, cell signalling and cell communication and the extracellular matrix (ECM) has provided important insights into the formation of myofibroblast and their function. Important new studies include investigations into the relationship between inflammation and myofibroblast production and further evidence has been gathered that reveal the importance of ECM microenvironment, biomechanical sensing and mechanotransduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This review highlights our current understanding and outlines the increasing complexity of the biological processes that leads to the appearance of the myofibroblast in normal functions and in diseased tissues. We also focus on areas of special interest in particular, studies that have therapeutic potential in fibrosis and scleroderma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000543","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T18:09:07Z","timestamp":1533146947000},"page":"581-587","source":"Crossref","is-referenced-by-count":28,"title":["Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?"],"prefix":"10.1097","volume":"30","author":[{"given":"Dafni A.","family":"Gyftaki-Venieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella","family":"Ponticos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","first-page":"171","article-title":"The role of myofibroblasts in wound healing","volume":"64","author":"Hinz","year":"2016","journal-title":"Curr Res Transl Med"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.matbio.2018.01.019","article-title":"The big five in fibrosis: macrophages, myofibroblasts, matrix, mechanics, and miscommunication","volume":"68-69","author":"Pakshir","year":"2018","journal-title":"Matrix Biol"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor? At the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1073\/pnas.85.14.5112","article-title":"Human skin fibroblasts in vitro differentiate along a terminal cell lineage","volume":"85","author":"Bayreuther","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-20230901","first-page":"69","article-title":"The mighty fibroblast and its utility in scleroderma research","volume":"2","author":"Garret","year":"2017","journal-title":"J scleroderma Relat Disord"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"pii: E2157","DOI":"10.3390\/ijms18102157","article-title":"TGF-\u03b2-induced endothelial-mesenchymal transition in fibrotic diseases","volume":"18","author":"Pardali","year":"2017","journal-title":"Int J Mol Sci [Internet]"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12783","article-title":"Distinct fibroblast lineages determine dermal architecture in skin development and repair","volume":"504","author":"Driskell","year":"2013","journal-title":"Nature"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"aaa2151","DOI":"10.1126\/science.aaa2151","article-title":"Identification and isolation of a dermal lineage with intrinsic fibrogenic potential","volume":"348","author":"Rinkevich","year":"2015","journal-title":"Science"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/PRS.0000000000002634","article-title":"Dipeptidyl peptidase-4, wound healing, scarring, and fibrosis","volume":"138","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jid.2017.09.045","article-title":"SFRP2\/DPP4 and FMO1\/LSP1 define major fibroblast populations in human skin","volume":"138","author":"Tabib","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jid.2018.01.016","article-title":"Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations","volume":"138","author":"Philippeos","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1 + mesenchymal stromal cells are a key driver of bone marrow fibrosis and an important cellular therapeutic target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2018-02-834820","article-title":"The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis","volume":"131","author":"Kramann","year":"2018","journal-title":"Blood"},{"key":"R17-20230901","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-213031","article-title":"Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the fasscinate clinical trial in systemic sclerosis","author":"Denton","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-016-1118-7","article-title":"A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator","volume":"18","author":"Bhattacharyya","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/wound.2017.0732","article-title":"Toll-like receptor-4 signaling drives persistent fibroblast activation and prevents fibrosis resolution in scleroderma","volume":"6","author":"Bhattacharyya","year":"2017","journal-title":"Adv Wound Care"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"232ra50","DOI":"10.1126\/scitranslmed.3008264","article-title":"Fibronectin EDA promotes chronic cutaneous fibrosis through toll-like receptor signaling","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci Transl Med"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-017-1331-z","article-title":"Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis","volume":"19","author":"Artlett","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2017.10.008","article-title":"Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing","volume":"129","author":"Piperigkou","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2217\/epi-2016-0150","article-title":"Epigenetic factors as drivers of fibrosis in systemic sclerosis","volume":"9","author":"Bergmann","year":"2017","journal-title":"Epigenomics [Internet]"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2016.11.001","article-title":"Targeting chromatin remodeling in inflammation and fibrosis","volume":"107","author":"Yang","year":"2017","journal-title":"Adv Protein Chem Struct Biol"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J Exp Med"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/annrheumdis-2018-213022","article-title":"Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts","volume":"77","author":"He","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2017-211501","article-title":"The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis","volume":"77","author":"Bergmann","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/annrheumdis-2017-212265","article-title":"Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis","volume":"77","author":"Zhang","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41416-018-0072-3","article-title":"Suppression of TGF\u03b2- mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition","volume":"118","author":"Kim","year":"2018","journal-title":"Br J Cancer"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"69321","DOI":"10.18632\/oncotarget.12504","article-title":"SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis","volume":"7","author":"Akamata","year":"2016","journal-title":"Oncotarget"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"101299","DOI":"10.11131\/2017\/101299","article-title":"The myofibroblast: TGF\u03b2-1, a conductor which plays a key role in fibrosis by regulating the balance between PPAR\u03b3 and the canonical WNT pathway","volume":"4","author":"Lecarpentier","year":"2017","journal-title":"Nucl Recept Res"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"10294","DOI":"10.18632\/oncotarget.23516","article-title":"The nonneuronal cyclin- dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target","volume":"9","author":"Wei","year":"2018","journal-title":"Oncotarget"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41467-017-01168-1","article-title":"PTP4A1 promotes TGF\u03b2 signaling and fibrosis in systemic sclerosis","volume":"8","author":"Sacchetti","year":"2017","journal-title":"Nat Commun"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"e0196559","DOI":"10.1371\/journal.pone.0196559","article-title":"Abrogation of transforming growth factor-\u03b2-induced tissue fibrosis in TBRIcaCol1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib)","volume":"13","author":"Wermuth","year":"2018","journal-title":"PLoS One"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2014-206234","article-title":"Tribbles homologue 3 stimulates canonical TGF-\u03b2 signalling to regulate fibroblast activation and tissue fibrosis","volume":"75","author":"Tomcik","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1038\/s41598-018-25992-7","article-title":"Metabolomic profile of systemic sclerosis patients","volume":"8","author":"Murgia","year":"2018","journal-title":"Sci Rep"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1165\/rcmb.2016-0186OC","article-title":"Targeting hypoxia- inducible factor-1\u03b1\/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis","volume":"58","author":"Goodwin","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-018-0710-z","article-title":"Matrix stiffness: the conductor of organ fibrosis","volume":"20","author":"Santos","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.matbio.2018.01.025","article-title":"New developments on skin fibrosis: essential signals emanating from the extracellular matrix for the control of myofibroblasts","volume":"68-69","author":"Schulz","year":"2018","journal-title":"Matrix Biol"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1681\/ASN.2015121354","article-title":"Yap\/Taz deletion in Gli+ cell-derived myofibroblasts attenuates fibrosis","volume":"28","author":"Liang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jid.2017.08.024","article-title":"Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis","volume":"138","author":"Toyama","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-018-1577-0","article-title":"Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts","volume":"20","author":"Cutolo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"e0180751","DOI":"10.1371\/journal.pone.0180751","article-title":"Increased dermal collagen bundle alignment in systemic sclerosis is associated with a cell migration signature and role of Arhgdib in directed fibroblast migration on aligned ECMs","volume":"12","author":"Cao","year":"2017","journal-title":"PLoS One"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ajpath.2017.05.005","article-title":"Adenosine A 2a receptor blockade diminishes Wnt\/\u03b2-catenin signaling in a murine model of bleomycin-induced dermal fibrosis","volume":"187","author":"Zhang","year":"2017","journal-title":"Am J Pathol"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"eaal3765","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002281-201811000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:51Z","timestamp":1786038831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201811000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000543","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}